2,3-bis(3'-hydroxybenzyl)butyrolactone and Disease Exacerbation

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behrens, S; Buck, K; Chang-Claude, J; Flesch-Janys, D; Heinz, J; Johnson, TS; Kaaks, R; Linseisen, J; Obi, N; Seibold, P; Vrieling, A	1

Reviews

1 review(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Disease Exacerbation

Article	Year
Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis. International journal of cancer, 2014, Aug-15, Volume: 135, Issue:4 Topics: 4-Butyrolactone; Aged; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Diet; Disease Progression; Disease-Free Survival; Female; Germany; Humans; Life Style; Lignans; Middle Aged; Postmenopause; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors	2014

Article

Year

Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.

International journal of cancer, 2014, Aug-15, Volume: 135, Issue:4

Topics: 4-Butyrolactone; Aged; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Diet; Disease Progression; Disease-Free Survival; Female; Germany; Humans; Life Style; Lignans; Middle Aged; Postmenopause; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors

2014